Tempest Therapeutics, Inc. Defined Contribution Plan, Cost
Tempest Therapeutics, Inc. (TPST) reported Defined Contribution Plan, Cost of $300.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2018-03-15
- Tempest Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2013-03-31 was $31.00K.
- Tempest Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2012-12-31 was $61.00K.
- Tempest Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2012-09-30 was $19.00K.
- Tempest Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2012-06-30 was $8.10K.
- Tempest Therapeutics, Inc. defined contribution plan, cost for fiscal 2017 was $300.00K, a 25.00% decline from fiscal 2016.
- Tempest Therapeutics, Inc. defined contribution plan, cost for fiscal 2016 was $400.00K, a 33.33% increase from fiscal 2015.
- Tempest Therapeutics, Inc. defined contribution plan, cost for fiscal 2015 was $300.00K, a 50.00% increase from fiscal 2014.
- Tempest Therapeutics, Inc. defined contribution plan, cost for fiscal 2014 was $200.00K, a 100.00% increase from fiscal 2013.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed | Defined Contribution Plan, Cost 21 month | Defined Contribution Plan, Cost 33 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $300.00K 10-K · filed 2018-03-15 | ||||||
| 2016-12-31 | $400.00K 10-K · filed 2018-03-15 | ||||||
| 2015-12-31 | $300.00K 10-K · filed 2018-03-15 | ||||||
| 2014-12-31 | $200.00K 10-K · filed 2017-03-02 | ||||||
| 2013-12-31 | $100.00K 10-K · filed 2016-02-26 | $200.00K 10-K · filed 2014-02-27 | |||||
| 2013-03-31 | $31.00K 10-Q · filed 2013-05-15 | $92.00K derived: sum of 2 quarters · filed 2015-03-16 | $111.00K derived: sum of 3 quarters · filed 2015-03-16 | $119.09K derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $80.00K derived: sum of 2 quarters · filed 2015-03-16 | $88.09K derived: sum of 3 quarters · filed 2015-03-16 | $100.00K 10-K · filed 2015-03-16 | $52.00K 10-K · filed 2013-02-25 | $52.00K 10-K · filed 2013-02-25 | |
| 2012-09-30 | $19.00K 10-Q · filed 2012-11-13 | $27.09K derived: sum of 2 quarters · filed 2012-11-13 | $39.00K 10-Q · filed 2012-11-13 | ||||
| 2012-06-30 | $8.10K 10-Q · filed 2012-08-14 | $19.86K 10-Q · filed 2012-08-14 | |||||
| 2011-12-31 | $0.00 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |